<DOC>
	<DOC>NCT01749059</DOC>
	<brief_summary>The purpose of this study is to evaluate the impact of implementing a universal pulse oximeter screening as a way to detect critical congenital heart disease in otherwise well-appearing newborns.</brief_summary>
	<brief_title>The Impact of Implementing a Universal Newborn Screening for Critical Congenital Heart Disease</brief_title>
	<detailed_description />
	<mesh_term>Heart Diseases</mesh_term>
	<mesh_term>Heart Defects, Congenital</mesh_term>
	<criteria>1. Documentation of informed consent and authorization. 2. Full term and late preterm newborns (EGA 3544 weeks) 3. On room air 4. Neonates known to have a congenital heart defect at the time of screening, e.g., antenatal diagnosis or diagnosis within the first 24 hours after birth 5. Parents agree to followup contact post discharge 1. On supplemental oxygen 2. Admitted to the Neonatal Intensive Care Unit 3. Parents do not agree to followup 4. Greater than 30 days of age</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>30 Days</maximum_age>
	<verification_date>December 2016</verification_date>
</DOC>